glp-1 covered by cigna dropping obesity drug coverage for employees (CI) cigna coverage for glp-1 drops

This is the same core mechanism of existing obesity treatments

It is a defended one

Weight cycling is harmful (the cycle of losing weight then regaining the weight) and may be linked to: Higher body fat percentage and slower metabolism over time weight loss involves losing both fat and muscle weight regain is mostly gaining fat body image issues and further weight cycling Greater risk for cardiovascular disease and insulin resistance Emotional distress and disordered eating patterns Its important to create and maintain personalized, long-term strategies that focus on behavioral changes and mindset shifts before, during, and after stopping GLP-1 medications

We suggest that it is time to stop referring to these structures as glial scars or astrocyte scars and instead refer to them as astrocyte borders or glial borders